High-throughput genomic profiling of tumor-infiltrating leukocytes

Current Opinion in Immunology

Volumn 41, Issue , 2016, Pages 77-84

  Newman, Aaron M ^a   Alizadeh, Ash A ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; CALIBRATION; COMPUTER MODEL; DNA DENATURATION; GENE EXPRESSION; HIGH THROUGHPUT SEQUENCING; HUMAN; MARKER GENE; REVIEW; SOLID TUMOR; TUMOR ASSOCIATED LEUKOCYTE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; NEOPLASM;

GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; NEOPLASMS;

EID: 84976438403     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2016.06.006     Document Type: Review

References (61)

1. Galon J., Costes A., Sanchez-Cabo F., Kirilovsky A., Mlecnik B., Lagorce-Pagès C., Tosolini M., Camus M., Berger A., Wind P., et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006, 313:1960-1964.
2. Hanahan D., Coussens L.M. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012, 21:309-322.
3. Junttila M.R., de Sauvage F.J. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 2013, 501:346-354.
4. Adams S., Gray R.J., Demaria S., Goldstein L., Perez E.A., Shulman L.N., Martino S., Wang M., Jones V.E., Saphner T.J., et al. Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. J Clin Oncol 2014, 32:2959-2966.
5. Tumeh P.C., Harview C.L., Yearley J.H., Shintaku I.P., Taylor E.J., Robert L., Chmielowski B., Spasic M., Henry G., Ciobanu V., et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 2014, 515:568-571.
6. Gentles A.J., Newman A.M., Liu C.L., Bratman S.V., Feng W., Kim D., Nair V.S., Xu Y., Khuong A., Hoang C.D., et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med 2015, 21:938-945.
7. Green M.R., Kihira S., Liu C.L., Nair R.V., Salari R., Gentles A.J., Irish J., Stehr H., Vicente-Duenas C., Romero-Camarero I., et al. Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation. Proc Natl Acad Sci U S A 2015, 112:E1116-E1125.
8. Rooney M.S., Shukla S.A., Wu C.J., Getz G., Hacohen N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell 2015, 160:48-61.
9. Mlecnik B., Bindea G., Kirilovsky A., Angell H.K., Obenauf A.C., Tosolini M., Church S.E., Maby P., Vasaturo A., Angelova M., et al. The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis. Sci Transl Med 2016, 8. 327ra326.
10. Chao M.P., Alizadeh A.A., Tang C., Myklebust J.H., Varghese B., Gill S., Jan M., Cha A.C., Chan C.K., Tan B.T., et al. Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. Cell 2010, 142:699-713.
11. Willingham S.B., Volkmer J.P., Gentles A.J., Sahoo D., Dalerba P., Mitra S.S., Wang J., Contreras-Trujillo H., Martin R., Cohen J.D., et al. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci U S A 2012, 109:6662-6667.
12. Ribas A. Releasing the brakes on cancer immunotherapy. N Engl J Med 2015, 373:1490-1492.
13. Schalper K.A., Kaftan E., Herbst R.S. Predictive biomarkers for PD-1 axis therapies: the hidden treasure or a call for research. Clin Cancer Res 2016, 22:2102-2104.
14. McGranahan N., Furness A.J., Rosenthal R., Ramskov S., Lyngaa R., Saini S.K., Jamal-Hanjani M., Wilson G.A., Birkbak N.J., Hiley C.T., et al. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science 2016, 351:1463-1469.
15. Hugo W., Shi H., Sun L., Piva M., Song C., Kong X., Moriceau G., Hong A., Dahlman K.B., Johnson D.B., et al. Non-genomic and immune evolution of melanoma acquiring MAPKi resistance. Cell 2015, 162:1271-1285.
16. Shen-Orr S.S., Gaujoux R. Computational deconvolution: extracting cell type-specific information from heterogeneous samples. Curr Opin Immunol 2013, 25:571-578.
17. Zhong Y., Wan Y.W., Pang K., Chow L.M., Liu Z. Digital sorting of complex tissues for cell type-specific gene expression profiles. BMC Bioinformatics 2013, 14:89.
18. Bendall S.C., Simonds E.F., Qiu P., Amir el A.D., Krutzik P.O., Finck R., Bruggner R.V., Melamed R., Trejo A., Ornatsky O.I., et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 2011, 332:687-696.
19. Robins H.S., Ericson N.G., Guenthoer J., O'Briant K.C., Tewari M., Drescher C.W., Bielas J.H. Digital genomic quantification of tumor-infiltrating lymphocytes. Sci Transl Med 2013, 5:214ra169.
20. Angelo M., Bendall S.C., Finck R., Hale M.B., Hitzman C., Borowsky A.D., Levenson R.M., Lowe J.B., Liu S.D., Zhao S., et al. Multiplexed ion beam imaging of human breast tumors. Nat Med 2014, 20:436-442.
21. Venet D., Pecasse F., Maenhaut C., Bersini H. Separation of samples into their constituents using gene expression data. Bioinformatics 2001, 17(Suppl. 1):S279-S287.
22. Lu P., Nakorchevskiy A., Marcotte E.M. Expression deconvolution: a reinterpretation of DNA microarray data reveals dynamic changes in cell populations. Proc Natl Acad Sci U S A 2003, 100:10370-10375.
23. Dave S.S., Wright G., Tan B., Rosenwald A., Gascoyne R.D., Chan W.C., Fisher R.I., Braziel R.M., Rimsza L.M., Grogan T.M., et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. New Engl J Med 2004, 351:2159-2169.
24. Abbas A.R., Wolslegel K., Seshasayee D., Modrusan Z., Clark H.F. Deconvolution of blood microarray data identifies cellular activation patterns in systemic lupus erythematosus. PLoS One 2009, 4:e6098.
25. Repsilber D., Kern S., Telaar A., Walzl G., Black G.F., Selbig J., Parida S.K., Kaufmann S.H., Jacobsen M. Biomarker discovery in heterogeneous tissue samples - taking the in-silico deconfounding approach. BMC Bioinformatics 2010, 11:27.
26. Shen-Orr S.S., Tibshirani R., Khatri P., Bodian D.L., Staedtler F., Perry N.M., Hastie T., Sarwal M.M., Davis M.M., Butte A.J. Cell type-specific gene expression differences in complex tissues. Nat Methods 2010, 7:287-289.
27. Gaujoux R., Seoighe C. Semi-supervised nonnegative matrix factorization for gene expression deconvolution: a case study. Infect Genet Evol 2012, 12:913-921.
28. Gong T., Hartmann N., Kohane I.S., Brinkmann V., Staedtler F., Letzkus M., Bongiovanni S., Szustakowski J.D. Optimal deconvolution of transcriptional profiling data using quadratic programming with application to complex clinical blood samples. PLoS One 2011, 6:e27156.
29. Kuhn A., Thu D., Waldvogel H.J., Faull R.L., Luthi-Carter R. Population-specific expression analysis (PSEA) reveals molecular changes in diseased brain. Nat Methods 2011, 8:945-947.
30. Qiao W., Quon G., Csaszar E., Yu M., Morris Q., Zandstra P.W. PERT: a method for expression deconvolution of human blood samples from varied microenvironmental and developmental conditions. PLoS Comput Biol 2012, 8:e1002838.
31. Bindea G., Mlecnik B., Tosolini M., Kirilovsky A., Waldner M., Obenauf A.C., Angell H., Fredriksen T., Lafontaine L., Berger A., et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 2013, 39:782-795.
32. Gong T., Szustakowski J.D. DeconRNASeq: a statistical framework for deconvolution of heterogeneous tissue samples based on mRNA-Seq data. Bioinformatics 2013, 29:1083-1085.
33. Nagalla S., Chou J.W., Willingham M.C., Ruiz J., Vaughn J.P., Dubey P., Lash T.L., Hamilton-Dutoit S.J., Bergh J., Sotiriou C., et al. Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis. Genome Biol 2013, 14:1-18.
34. Yoshihara K., Shahmoradgoli M., Martinez E., Vegesna R., Kim H., Torres-Garcia W., Trevino V., Shen H., Laird P.W., Levine D.A., et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 2013, 4:2612.
35. Zuckerman N.S., Noam Y., Goldsmith A.J., Lee P.P. A self-directed method for cell-type identification and separation of gene expression microarrays. PLoS Comput Biol 2013, 9:e1003189.
36. Altboum Z., Steuerman Y., David E., Barnett-Itzhaki Z., Valadarsky L., Keren-Shaul H., Meningher T., Mendelson E., Mandelboim M., Gat-Viks I., et al. Digital cell quantification identifies global immune cell dynamics during influenza infection. Mol Syst Biol 2014, 10:720.
37. Liebner D.A., Huang K., Parvin J.D. MMAD: microarray microdissection with analysis of differences is a computational tool for deconvoluting cell type-specific contributions from tissue samples. Bioinformatics 2014, 30:682-689.
38. Chikina M., Zaslavsky E., Sealfon S.C. CellCODE: a robust latent variable approach to differential expression analysis for heterogeneous cell populations. Bioinformatics 2015, 31:1584-1591.
39. Mohammadi S, Zuckerman N, Goldsmith A, Grama A: A critical survey of deconvolution methods for separating cell-types in complex tissues. In ArXiv 2015, http://arxiv.org/abs/1510.04583v1.
40. Moffitt R.A., Marayati R., Flate E.L., Volmar K.E., Loeza S.G., Hoadley K.A., Rashid N.U., Williams L.A., Eaton S.C., Chung A.H., et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat Genet 2015, 47:1168-1178.
41. Newman A.M., Liu C.L., Green M.R., Gentles A.J., Feng W., Xu Y., Hoang C.D., Diehn M., Alizadeh A.A. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods 2015, 12:453-457.
42. Senbabaoglu Y., Winer A.G., Gejman R.S., Liu M., Luna A., Ostrovnaya I., Weinhold N., Lee W., Kaffenberger S.D., Chen Y.B., et al. The landscape of T cell infiltration in human cancer and its association with antigen presenting gene expression. bioRxiv 2015, http://dx.doi.org/10.1101/025908.
43. Tirosh I., Izar B., Prakadan S.M., Wadsworth M.H., Treacy D., Trombetta J.J., Rotem A., Rodman C., Lian C., Murphy G., et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 2016, 352:189-196.
44. Ju W., Greene C.S., Eichinger F., Nair V., Hodgin J.B., Bitzer M., Lee Y.S., Zhu Q., Kehata M., Li M., et al. Defining cell-type specificity at the transcriptional level in human disease. Genome Res 2013, 23:1862-1873.
45. Hong W.J., Warnke R., Chu G. Immune signatures in follicular lymphoma. N Engl J Med 2005, 352:1496-1497. (author reply).
46. Angelova M., Charoentong P., Hackl H., Fischer M.L., Snajder R., Krogsdam A.M., Waldner M.J., Bindea G., Mlecnik B., Galon J., et al. Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy. Genome Biol 2015, 16:64.
47. Barbie D.A., Tamayo P., Boehm J.S., Kim S.Y., Moody S.E., Dunn I.F., Schinzel A.C., Sandy P., Meylan E., Scholl C., et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 2009, 462:108-112.
48. Bolen C.R., Uduman M., Kleinstein S.H. Cell subset prediction for blood genomic studies. BMC Bioinformatics 2011, 12:258.
49. Gaujoux R., Seoighe C. CellMix: a comprehensive toolbox for gene expression deconvolution. Bioinformatics 2013, 29:2211-2212.
50. Abbas A.R., Baldwin D., Ma Y., Ouyang W., Gurney A., Martin F., Fong S., van Lookeren Campagne M., Godowski P., Williams P.M., et al. Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data. Genes Immun 2005, 6:319-331.
51. Hastie T., Tibshirani R., Friedman J. The Elements of Statistical Learning 2001, Springer, New York Inc.
52. Farrar D.E., Glauber R.R. Multicollinearity in regression analysis: the problem revisited. Rev Econ Stat 1967, 49:92-107.
53. Karpinski P., Frydecka D., Sasiadek M.M., Misiak B. Reduced number of peripheral natural killer cells in schizophrenia but not in bipolar disorder. Brain Behav Immun 2016, 54:194-200.
54. Araujo J.M., Prado A., Cardenas N.K., Zaharia M., Dyer R., Doimi F., Bravo L., Pinillos L., Morante Z., Aguilar A., et al. Repeated observation of immune gene sets enrichment in women with non-small cell lung cancer. Oncotarget 2016, 7:20282-20292.
55. Vinayak S., Gray R.J., Adams S., Jensen K.C., Manola J., Afghahi A., Goldstein L.J., Ford J.M., Badve S.S., Telli M.L. Association of increased tumor-infiltrating lymphocytes (TILs) with immunomodulatory (IM) triple-negative breast cancer (TNBC) subtype and response to neoadjuvant platinum-based therapy in PrECOG0105. ASCO Meeting Abst 2014, 32:1000.
56. Wang Q., Hu X., Muller F., Kim H., Squatrito M., Millelsen T., Scarpace L., Barthel F., Lin Y.-H., Satani N., et al. Tumor evolution of glioma intrinsic gene expression subtype associates with immunological changes in the microenvironment. bioRxiv 2016, http://dx.doi.org/10.1101/052076.
57. Mehnert J.M., Panda A., Zhong H., Hirshfield K., Damare S., Lane K., Sokol L., Stein M.N., Rodriguez-Rodriquez L., Kaufman H.L., et al. Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer. J Clin Invest 2016, 10.1172/JCI84940.
58. Wang C., Gong B., Bushel P.R., Thierry-Mieg J., Thierry-Mieg D., Xu J., Fang H., Hong H., Shen J., Su Z., et al. The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance. Nat Biotech 2014, 32:926-932.
59. Zhao S., Fung-Leung W.-P., Bittner A., Ngo K., Liu X. Comparison of RNA-Seq and microarray in transcriptome profiling of activated T cells. PLoS ONE 2014, 9:e78644.
60. Yuan Y., Failmezger H., Rueda O.M., Ali H.R., Graf S., Chin S.F., Schwarz R.F., Curtis C., Dunning M.J., Bardwell H., et al. Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling. Sci Transl Med 2012, 4. 157ra143.
61. Aran D., Sirota M., Butte A.J. Systematic pan-cancer analysis of tumour purity. Nat Commun 2015, 6:8971.